|
1
|
Steinman RM: The dendritic cell system and
its role in immunogenicity. Annu Rev Immunol. 9:271–296. 1991.
|
|
2
|
Nestle FO, Burg G, Fäh J, Wrone-Smith T
and Nickoloff BJ: Human sunlight-induced
basal-cell-carcinoma-associated dendritic cells are deficient in T
cell co-stimulatory molecules and are impaired as
antigen-presenting cells. Am J Pathol. 150:641–651. 1997.
|
|
3
|
Watkins SK, Zhu Z, Riboldi E, et al: FOXO3
programs tumor-associated DCs to become tolerogenic in human and
murine prostate cancer. J Clin Invest. 121:1361–1372. 2011.
|
|
4
|
Kuo CH, Chen KF, Chou SH, et al: Lung
tumor-associated dendritic cell-derived resistin promoted cancer
progression by increasing Wolf-Hirschhorn syndrome candidate
1/Twist pathway. Carcinogenesis. 34:2600–2609. 2013.
|
|
5
|
Kuo PL, Huang MS, Cheng DE, Hung JY, Yang
CJ and Chou SH: Lung cancer-derived galectin-1 enhances tumorigenic
potentiation of tumor-associated dendritic cells by expressing
heparin-binding EGF-like growth factor. J Biol Chem. 287:9753–9764.
2012.
|
|
6
|
Hsu YL, Huang MS, Cheng DE, et al: Lung
tumor-associated dendritic cell-derived amphiregulin increased
cancer progression. J Immunol. 187:1733–1744. 2011.
|
|
7
|
Han Y, Chen Z, Yang Y, et al: Human
CD14+ CTLA-4+ regulatory dendritic cells
suppress T cell response via cytotoxic T-lymphocyte
antigen-4-dependent IL-10 and indoleamine-2,3-dioxygenase
production in hepatocellular carcinoma. Hepatology. 59:567–579.
2013.
|
|
8
|
Lindenberg JJ, Oosterhoff D, Sombroek CC,
et al: IL-10 conditioning of human skin affects the distribution of
migratory dendritic cell subsets and functional T cell
differentiation. PloS One. 8:e702372013.
|
|
9
|
Kuo PL, Hung JY, Huang SK, et al: Lung
cancer-derived galectin-1 mediates dendritic cell anergy through
inhibitor of DNA binding 3/IL-10 signaling pathway. J Immunol.
186:1521–1530. 2011.
|
|
10
|
Lindenberg JJ, van de Ven R, Lougheed SM,
et al: Functional characterization of a STAT3-dependent dendritic
cell-derived CD14 cell population arising upon IL-10-driven
maturation. Oncoimmunology. 2:e238372013.
|
|
11
|
Donnelly RP, Dickensheets H and Finbloom
DS: The interleukin-10 signal transduction pathway and regulation
of gene expression in mononuclear phagocytes. J Interferon Cytokine
Res. 19:563–573. 1999.
|
|
12
|
Sato K, Nagayama H, Tadokoro K, Juji T and
Takahashi TA: Extracellular signal-regulated kinase,
stress-activated protein kinase/c-Jun N-terminal kinase, and
p38mapk are involved in IL-10-mediated selective repression of
TNF-α-induced activation and maturation of human peripheral blood
monocyte-derived dendritic cells. J Immunol. 162:3865–3872.
1999.
|
|
13
|
Staples KJ, Smallie T, Williams LM, et al:
IL-10 induces IL-10 in primary human monocyte-derived macrophages
via the transcription factor Stat3. J Immunol. 178:4779–4785.
2007.
|
|
14
|
Niemand C, Nimmesgern A, Haan S, et al:
Activation of STAT3 by IL-6 and IL-10 in primary human macrophages
is differentially modulated by suppressor of cytokine signaling 3.
J Immunol. 170:3263–3272. 2003.
|
|
15
|
Porcu M, Kleppe M, Gianfelici V, et al:
Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in
T-cell acute lymphoblastic leukemia. Blood. 119:4476–4479.
2012.
|
|
16
|
Xu D and Qu CK: Protein tyrosine
phosphatases in the JAK/STAT pathway. Front Biosci. 13:4925–4932.
2008.
|
|
17
|
Irie-Sasaki J, Sasaki T, Matsumoto W, et
al: CD45 is a JAK phosphatase and negatively regulates cytokine
receptor signalling. Nature. 409:349–354. 2001.
|
|
18
|
McFarland EC, Hurley TR, Pingel JT, Sefton
BM, Shaw A and Thomas ML: Correlation between Src family member
regulation by the protein-tyrosine-phosphatase CD45 and
transmembrane signaling through the T-cell receptor. Proc Natl Acad
Sci USA. 90:1402–1406. 1993.
|
|
19
|
Hurley TR, Hyman R and Sefton BM:
Differential effects of expression of the CD45 tyrosine protein
phosphatase on the tyrosine phosphorylation of the lck, fyn, and
c-src tyrosine protein kinases. Mol Cell Biol. 13:1651–1656.
1993.
|
|
20
|
Bataille R, Robillard N, Pellat-Deceunynck
C and Amiot M: A cellular model for myeloma cell growth and
maturation based on an intraclonal CD45 hierarchy. Immunol Rev.
194:105–111. 2003.
|
|
21
|
Fulcher JA, Chang MH, Wang S, et al:
Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces
cell activation and migration through Syk and protein kinase C
signaling. J Biol Chem. 284:26860–26870. 2009.
|
|
22
|
Descamps G, Pellat-Deceunynck C, Szpak Y,
Bataille R, Robillard N and Amiot M: The magnitude of
Akt/phosphatidylinositol 3′-kinase proliferating signaling is
related to CD45 expression in human myeloma cells. J Immunol.
173:4953–4959. 2004.
|
|
23
|
Ishikawa H, Mahmoud MS, Fujii R, Abroun S
and Kawano MM: Proliferation of immature myeloma cells by
interleukin-6 is associated with CD45 expression in human multiple
myeloma. Leuk Lymphoma. 39:51–55. 2000.
|
|
24
|
Timmerman JM and Levy R: Dendritic cell
vaccines for cancer immunotherapy. Ann Rev Med. 50:507–529.
1999.
|
|
25
|
Théry C and Amigorena S: The cell biology
of antigen presentation in dendritic cells. Curr Opin Immunol.
13:45–51. 2001.
|
|
26
|
Dunn GP, Bruce AT, Ikeda H, Old LJ and
Schreiber RD: Cancer immunoediting: from immunosurveillance to
tumor escape. Nat Immunol. 3:991–998. 2002.
|
|
27
|
Almand B, Resser JR, Lindman B, et al:
Clinical significance of defective dendritic cell differentiation
in cancer. Clin Cancer Res. 6:1755–1766. 2000.
|
|
28
|
Gabrilovich DI, Chen HL, Girgis KR, et al:
Production of vascular endothelial growth factor by human tumors
inhibits the functional maturation of dendritic cells. Nat Med.
2:1096–1103. 1996.
|
|
29
|
Steinbrink K, Jonuleit H, Müller G,
Schuler G, Knop J and Enk AH: Interleukin-10-treated human
dendritic cells induce a melanoma-antigen-specific anergy in CD8(+)
T cells resulting in a failure to lyse tumor cells. Blood.
93:1634–1642. 1999.
|
|
30
|
Qin Z, Noffz G, Mohaupt M and Blankenstein
T: Interleukin-10 prevents dendritic cell accumulation and
vaccination with granulocyte-macrophage colony-stimulating factor
gene-modified tumor cells. J Immunol. 159:770–776. 1997.
|
|
31
|
Gregori S, Tomasoni D, Pacciani V, et al:
Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic
DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood.
116:935–944. 2010.
|
|
32
|
Bhattacharyya S, Sen P, Wallet M, Long B,
Baldwin AS and Tisch R: Immunoregulation of dendritic cells by
IL-10 is mediated through suppression of the PI3K/Akt pathway and
of IkappaB kinase activity. Blood. 104:1100–1109. 2004.
|
|
33
|
Song GY, Chung CS, Schwacha MG, Jarrar D,
Chaudry IH and Ayala A: Splenic immune suppression in sepsis: A
role for IL-10-induced changes in P38 MAPK signaling. J Surg Res.
83:36–43. 1999.
|
|
34
|
Arimura Y, Ogimoto M, Mitomo K, et al:
CD45 is required for CD40-induced inhibition of DNA synthesis and
regulation of c-Jun NH2-terminal kinase and p38 in BAL-17 B cells.
J Biol Chem. 276:8550–8556. 2001.
|
|
35
|
Hayes AL, Smith C, Foxwell BM and Brennan
FM: CD45-induced tumor necrosis factor alpha production in
monocytes is phosphatidylinositol 3-kinase-dependent and nuclear
factor-kappaB-independent. J Biol Chem. 274:33455–33461. 1999.
|
|
36
|
Hoffman JF, Linderman JJ and Omann GM:
Receptor up-regulation, internalization, and interconverting
receptor states Critical components of a quantitative description
of N-formyl peptide-receptor dynamics in the neutrophil. J Biol
Chem. 271:18394–18404. 1996.
|
|
37
|
Kutsumi H, Kawai K, Johnston RB Jr and
Rokutan K: Evidence for participation of vicinal dithiols in the
activation sequence of the respiratory burst of human neutrophils.
Blood. 85:2559–2569. 1995.
|
|
38
|
Planat V, Tronchere H, Record M, Ribbes G
and Chap H: Involvement of vicinal dithiols in differential
regulation of fMLP and phorbol ester-activated phospholipase D in
stimulated human neutrophils. Biochem Biophys Res Commun.
218:847–853. 1996.
|
|
39
|
Dowling P and Clynes M: Conditioned media
from cell lines: a complementary model to clinical specimens for
the discovery of disease-specific biomarkers. Proteomics.
11:794–804. 2011.
|
|
40
|
Bailey C, Negus R, Morris A, et al:
Chemokine expression is associated with the accumulation of tumour
associated macrophages (TAMs) and progression in human colorectal
cancer. Clin Exp Metastasis. 24:121–130. 2007.
|
|
41
|
Ghosh D, Yu H, Tan XF, et al:
Identification of key players for colorectal cancer metastasis by
iTRAQ quantitative proteomics profiling of isogenic SW480 and SW620
cell lines. J Proteome Res. 10:4373–4387. 2011.
|
|
42
|
Ma C, Rong Y, Radiloff DR, et al:
Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of
colon cancer by enhancing cell extravasation. Genes Dev.
22:308–321. 2008.
|
|
43
|
Coffey RJ Jr, Shipley GD and Moses HL:
Production of transforming growth factors by human colon cancer
lines. Cancer Res. 46:1164–1169. 1986.
|
|
44
|
Anzano MA, Rieman D, Prichett W,
Bowen-Pope DF and Greig R: Growth factor production by human colon
carcinoma cell lines. Cancer Res. 49:2898–2904. 1989.
|
